• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIABETES CARE, INC. ACCU-CHEK ® FLEXLINK INFUSION SET; SUBCUTANEOUS INFUSION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIABETES CARE, INC. ACCU-CHEK ® FLEXLINK INFUSION SET; SUBCUTANEOUS INFUSION SET Back to Search Results
Lot Number ASKU
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Unspecified Infection (1930); Reaction, Injection Site (2442)
Event Date 01/16/2019
Event Type  Injury  
Manufacturer Narrative
The event occurred outside of the united states.While this product is not sold in the united states, it is like or similar to a product marketed in the united states.
 
Event Description
It was reported that the patient experienced inflammation at the insertion site of the flexlink cannula.This inflammation evolved into a local infection and patient went to the emergency room.At the hospital, the patient was given "inflammatory" and antibiotic treatment prescribed by the doctor.It is unknown how long the patient was hospitalized.The lot number was not provided.The infusion set was requested to be returned for product evaluation.
 
Event Description
It was reported that the patient experienced inflammation at the insertion site of the flexlink cannula.This inflammation evolved into a local infection and patient went to the emergency room.At the hospital, the patient was given "inflammatory" and antibiotic treatment prescribed by the doctor.It is unknown how long the patient was hospitalized.The lot number was not provided.The infusion set was requested to be returned for product evaluation.Additional information: the patient was contacted via phone on (b)(4) 2019 and she reported that on the third day of use of the cannula, she felt irritation so she removed the cannula from the site (left flank) and found that the site was purple and the skin was hardened and swollen.She went to a public hospital, where she was attended by a general physician, who prescribed the antibiotic foritus for 5 days and advised her to not insert a cannula back in this site.She reported that she has completed the medication.She indicated that there is a little lump at the site and that she is in good health.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACCU-CHEK ® FLEXLINK INFUSION SET
Type of Device
SUBCUTANEOUS INFUSION SET
Manufacturer (Section D)
ROCHE DIABETES CARE, INC.
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
UNOMEDICAL DEVICES S.A. DE C.V
avenida fomento industrial lot
parque industrial del norte
reynosa C.P. 8873
MX   C.P. 88736
Manufacturer Contact
greg smith
9115 hague road
na
indianapolis, IN 46250-0457
3175212484
MDR Report Key8285549
MDR Text Key134355458
Report Number3011393376-2019-00400
Device Sequence Number1
Product Code FPA
Combination Product (y/n)N
Reporter Country CodeBR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 02/14/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/29/2019
Is this an Adverse Event Report? Yes
Device Operator Lay User/Patient
Device Lot NumberASKU
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received01/30/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage N
Patient Sequence Number1
Treatment
FORITUS
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age21 YR
-
-